ADAM15 and chronic obstructive pulmonary disease: Thus, our ADAM15 over-expression results in THP-1 cells suggest that the increased ADAM15 levels detected in AMs in patients with COPD versus controls (and in GOLD II-IV versus GOLD I-II) is not an epiphenomenon.